lentinan has been researched along with Experimental Neoplasms in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (62.50) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, J; Jin, W; Yang, Q; Yi, W; Yoo, S; Zhang, P | 1 |
| Ebina, T | 2 |
| Fukushima, M; Mushiake, H; Nukatsuka, M; Shimao, K; Tahara, H; Tsunoda, T | 1 |
| Fujimoto, S; Kaneko, Y; Maruyama, S; Sukekawa, Y | 1 |
| Chihara, G; Maeda, YY; Shiio, T; Suga, T | 1 |
| Chihara, G | 3 |
| Miwa, H; Moriya, N; Orita, K | 1 |
| Chihara, G; Hamuro, J; Maeda, YY | 1 |
| Miwa, H; Moriya, N; Orita, K; Taketsuka, S | 1 |
| Abe, S; Mizuno, D; Takahashi, K; Tsubouchi, J; Yamazaki, M | 1 |
| Akiyama, Y; Hamuro, J | 1 |
| Abe, S; Kimura, S; Mizuno, DI; Ohnishi, M; Oshima, H; Yamaguchi, H; Yamazaki, M | 1 |
| Hamuro, J; Röllinghoff, M; Wagner, H | 1 |
| Hamuro, J; Higuchi, S; Miwa, K; Suzuki, M; Taki, S; Taki, Y | 1 |
| Harada, T; Kan, N; Mise, K; Ohgaki, K; Okino, T; Satoh, K; Teramura, Y; Tobe, T; Yamasaki, S | 1 |
| Chihara, C; Maeda, YY; Rokutanda, M; Watanabe, ST | 1 |
| Akimoto, M; Mori, S; Nishihira, T | 1 |
| Chihara, G; Hamuro, J; Maeda, YY; Sasaki, T; Shiio, T; Suga, T; Takasuka, N | 1 |
| Hayashibara, H; Moriyuki, H; Niitsu, I; Ohishi, K; Shiio, T; Tsuchiya, Y; Yoshihama, T | 1 |
| Akimoto, M; Kasai, M; Nishihira, T | 1 |
| Abe, S; Gatanaga, T; Mizuno, D; Takahashi, K; Yamazaki, M | 1 |
3 review(s) available for lentinan and Experimental Neoplasms
| Article | Year |
|---|---|
Current status and perspectives of immunomodulators of microbial origin.
Topics: Adjuvants, Immunologic; Animals; Bacteria; BCG Vaccine; Blood Proteins; Carbohydrate Conformation; Chemical Phenomena; Chemistry; Colonic Neoplasms; Fungi; Glucans; Humans; Immunotherapy; Infections; Lentinan; Lymphocytes; Macrophage Activation; Neoplasms, Experimental; Picibanil; Polysaccharides; Proteoglycans; Rectal Neoplasms; Sizofiran; Stomach Neoplasms; Structure-Activity Relationship | 1982 |
Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Animals; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Humans; Immunity, Innate; Immunotherapy; Infections; Lentinan; Mice; Mice, Inbred Strains; Models, Biological; Neoplasms; Neoplasms, Experimental; Polysaccharides; Remission Induction; Survival Rate; Tegafur | 1992 |
Antitumor and metastasis-inhibitory activities of lentinan as an immunomodulator: an overview.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Immunotherapy; Lentinan; Neoplasm Metastasis; Neoplasms, Experimental; Polysaccharides | 1987 |
3 trial(s) available for lentinan and Experimental Neoplasms
| Article | Year |
|---|---|
Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Animals; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Humans; Immunity, Innate; Immunotherapy; Infections; Lentinan; Mice; Mice, Inbred Strains; Models, Biological; Neoplasms; Neoplasms, Experimental; Polysaccharides; Remission Induction; Survival Rate; Tegafur | 1992 |
[Modulation of anticancer effects of immunochemotherapeutic agents in various nutritional environments].
Topics: Animal Nutritional Physiological Phenomena; Animals; Antineoplastic Agents; Biological Products; Humans; Interleukin-2; Lentinan; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nutritional Physiological Phenomena; Picibanil; Polysaccharides; Stomach Neoplasms | 1988 |
[Modulation of the anti-tumor effect of BRM under various nutritional or endocrine conditions].
Topics: Animals; Combined Modality Therapy; Endocrine Glands; Female; Fluorouracil; Humans; Lentinan; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasms; Neoplasms, Experimental; Nutritional Physiological Phenomena; Picibanil; Stomach Neoplasms | 1986 |
19 other study(ies) available for lentinan and Experimental Neoplasms
| Article | Year |
|---|---|
A carbon nanotube-gemcitabine-lentinan three-component composite for chemo-photothermal synergistic therapy of cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Delivery Systems; Female; Gemcitabine; Humans; Laser Therapy; Lasers; Lentinan; MCF-7 Cells; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanotubes, Carbon; Neoplasms, Experimental; Phototherapy; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Thermogravimetry; Xenograft Model Antitumor Assays | 2018 |
[Activation of antitumor immunity by intratumor injection of biological preparations].
Topics: Adjuvants, Immunologic; Agaricus; Animals; Antineoplastic Agents; Glucans; Immunologic Factors; Injections, Intralesional; Lentinan; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Picibanil; Proteoglycans | 2003 |
Dendritic cells might be one of key factors for eliciting antitumor effect by chemoimmunotherapy in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combined Modality Therapy; Dendritic Cells; Drug Combinations; Fibrosarcoma; Immunotherapy, Adoptive; Lentinan; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms, Experimental; Oxonic Acid; Pyridines; Rats; Rats, Inbred Strains; Spleen; Survival Rate; T-Lymphocytes, Cytotoxic; Tegafur | 2005 |
[Antitumor effects of intratumoral injection of Basidiomycetes preparations].
Topics: Agaricus; Animals; Antibiotics, Antineoplastic; Basidiomycota; beta-Glucans; Immunologic Factors; Injections, Intralesional; Lentinan; Macrophage Activation; Male; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Neoplasms, Experimental; Plant Structures; Protein Binding; Proteoglycans | 2005 |
[Anti tumor activities of lentinan and micellapist in tumor-bearing mice].
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Antineoplastic Agents; beta-Glucans; CD4 Antigens; CD8 Antigens; Dietary Supplements; Endrin; Lentinan; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Plant Extracts; Shiitake Mushrooms | 2006 |
Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Evaluation, Preclinical; Fibrosarcoma; Lentinan; Methylcholanthrene; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Polysaccharides; Sarcoma 180; Species Specificity | 1984 |
Preclinical evaluation of lentinan in animal models.
Topics: Adjuvants, Immunologic; Animals; Drug Evaluation, Preclinical; Lentinan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Polysaccharides; T-Lymphocytes | 1983 |
Antitumor effect of bacterial lipopolysaccharide (LPS) alone and in combination with lentinan on MH-134 tumors in C3H/He mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Glycoproteins; Hypersensitivity, Delayed; Lentinan; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Polysaccharides; Tumor Necrosis Factor-alpha | 1984 |
[Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor].
Topics: Animals; Antineoplastic Agents; Drug Therapy, Combination; Female; Lentinan; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasms, Experimental; Polysaccharides; Rabbits | 1983 |
Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Cyclophosphamide; Drug Therapy, Combination; Lentinan; Leukemia L1210; Lipopolysaccharides; Liver Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Polysaccharides; Prognosis | 1982 |
[Effect of antitumor polysaccharides on specific and nonspecific immune responses and their immunological characteristics (author's transl)].
Topics: Animals; Antineoplastic Agents; Complement Pathway, Alternative; Cytotoxicity, Immunologic; Lentinan; Macrophage Activation; Mice; Mice, Inbred DBA; Mice, Inbred ICR; Neoplasms, Experimental; Polysaccharides; Sarcoma 180 | 1981 |
Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
Topics: Animals; Antineoplastic Agents; Body Weight; Bordetella pertussis; Cell Line; Cyclophosphamide; Drug Screening Assays, Antitumor; Escherichia coli; Fibrosarcoma; Gram-Negative Bacteria; Lentinan; Lethal Dose 50; Lipopolysaccharides; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred ICR; Neoplasms, Experimental; Tumor Cells, Cultured | 1994 |
Beta (1-3) glucans as a probe for T cell specific immune adjuvants. II. Enhanced in vitro generation of cytotoxic T lymphocytes.
Topics: Adjuvants, Immunologic; Animals; Antigens; Cytotoxicity, Immunologic; Dose-Response Relationship, Immunologic; Lentinan; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred CBA; Neoplasms, Experimental; Polysaccharides; T-Lymphocytes; Trinitrobenzenes | 1978 |
Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2.
Topics: Animals; Drug Therapy, Combination; Immunotherapy, Adoptive; Interleukin-2; Killer Cells, Lymphokine-Activated; Lentinan; Mice; Mice, Inbred C3H; Neoplasms, Experimental | 1990 |
[Experimental study on the optimal treatment schedule for combination of BRM (immunostimulators, cultured killer cells or interleukin-2) and chemotherapy].
Topics: Adjuvants, Immunologic; Animals; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Immunization, Passive; Immunologic Factors; Interleukin-2; Killer Cells, Lymphokine-Activated; Lentinan; Mice; Mice, Inbred BALB C; Neoplasms, Experimental | 1990 |
Denaturation and renaturation of a beta-1,6;1,3-glucan, lentinan, associated with expression of T-cell-mediated responses.
Topics: Acute-Phase Proteins; Animals; Dimethyl Sulfoxide; Female; Hemorrhage; Immunity, Cellular; Immunotherapy; Lentinan; Mice; Mice, Inbred Strains; Molecular Conformation; Neoplasms, Experimental; Polysaccharides; Sodium Hydroxide; Structure-Activity Relationship; T-Lymphocytes; Urea | 1988 |
[Combined use of lentinan with X-ray therapy in an experimental mouse tumor system (Part 2). Combined effect on the MM102 syngeneic tumor].
Topics: Animals; Combined Modality Therapy; Female; Lentinan; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Polysaccharides; Radiotherapy Dosage | 1988 |
Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Dactinomycin; Doxorubicin; Glycoproteins; Growth Inhibitors; Lentinan; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mitomycin; Mitomycins; Neoplasms, Experimental; Polysaccharides; Tumor Necrosis Factor-alpha | 1985 |
[Experimental studies on growth inhibition and regression of cancer metastases].
Topics: Animals; Combined Modality Therapy; Fibrosarcoma; Humans; Lentinan; Liver Neoplasms, Experimental; Lung Neoplasms; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Regression, Spontaneous; Neoplasms, Experimental; Rats | 1985 |